The overexpression of cyclin D is frequently associated with poor prognosis in cancer patients. High levels of cyclin D can indicate aggressive tumor behavior and resistance to standard therapies. Therefore, measuring cyclin D levels can be valuable for predicting patient outcomes and tailoring treatment strategies.
